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What are the indications 
for evaluating a patient 
with cough for pertussis?
■ EVIDENCE-BASED ANSWER
Pertussis should be considered in infants with
apnea or severe coughing illnesses of any dura-
tion, and in older children or adults with pro-
longed cough (eg, longer than 2 weeks), especial-
ly if accompanied by inspiratory whoop or house-
hold exposure to a prolonged cough illness
(strength of recommendation [SOR]: B, based on
consecutive cohort studies with poor reference
standards). Coughing paroxysms, posttussive
vomiting, and absence of fever, while typical of
pertussis, are of little help in distinguishing it
from other causes of prolonged coughing illnesses
(SOR: B, based on consecutive cohort studies
with poor reference standards). 
■ EVIDENCE SUMMARY
Pertussis is an important cause of cough in all
age groups. Ten prevalence studies of adoles-
cents and adults seeking medical attention for a
prolonged cough (defined variously as >1–4
weeks) found acute pertussis in 12% to 32%.1
While cough longer than 2 weeks, inspiratory
whoop, posttussive vomiting, coughing parox-
ysms, and absence of fever are commonly associ-
ated with pertussis, relatively few studies have
assessed the sensitivities and specificities of
these symptoms. The Table summarizes results
from 5 cohort series of children and adults with
laboratory-confirmed pertussis. Comparison
groups were variously defined by negative per-
tussis cultures, negative pertussis serology, or
serologic confirmation of other respiratory infec-
tions. Likelihood ratios (LR) were calculated
from the data presented in each paper.
The magnitude and variability of these likeli-
hood ratios suggest that individual symptoms may
be of limited help in distinguishing pertussis from
other causes of prolonged cough. Combinations of
symptoms may be slightly more helpful. In a study
comparing 10 patients with culture-confirmed per-
tussis with 10 patients with serologically con-
firmed mycoplasma pneumonia, the combination of
cough >14 days and whoop had a sensitivity of
80%, a positive LR (LR+) of 8 and a negative LR
(LR–) of 0.22.2 A cohort series of children aged <5
years with suspected pertussis compared 33 with
positive cultures to 55 with negative cultures. The
constellation of spasmodic cough and lymphocyto-
sis (>10,000) had a sensitivity of 83%, a LR+ of
2.5, and a LR– of 0.25. Cough >14 days with
whoop and vomiting had a sensitivity of 67%, a
LR+ of 3.2, and LR– of 0.42.3
Infants aged <6 months with pertussis are at par-
ticular risk for atypical presentations and serious
complications. In a US series of 18,500 infants with
pertussis, apnea was seen in 64% of infants under 1
month and in 44% between 6 and 11 months. Forty
percent of the 6- to 11-month-olds had received at
least 3 doses of pertussis vaccine.4 A British study of
126 infants aged <5 months admitted to the pedi-
atric intensive care unit with apnea, bradycardia, or
respiratory failure found that 20% had pertussis.
Apnea as a predictor of pertussis had a sensitivity of
68% and a specificity of 60%.5
Pertussis should be considered early in the
evaluation of young infants with cough. In a case-
control study comparing 15 fatal cases of pertus-
sis with 32 who survived (infants aged <6
months), the mean number of days from symptom
onset to hospital admission were 5.3 (fatal) and
8.6 (survivors). Rates of apnea on admission were
40% and 52%.6 A case series of 9 infants aged <7
weeks requiring admission to an intensive care
unit for pertussis found that 8 had been sick for
less than 4 days at the time of admission. All 9
presented with poor feeding and cough, and 5 had
experienced apnea.7
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C O N T I N U E D
OTHERS
The Centers for Disease Control and Prevention
and the World Health Organization describe the
clinical case definition for pertussis as a cough 
illness lasting at least 2 weeks with at least 1 of
the following: paroxysms of coughing, inspiratory
whoop, or posttussive vomiting, without other
apparent cause. Laboratory criteria for diagnosis
include a positive Bordetella pertussis culture or 
a positive polymerase chain reaction (PCR) for 
B pertussis.8,9
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Clinical features of pertussis
History Sensitivity Specificity LR+ LR–
Cough >2 weeks3,12 84%–100% 35%–36% 1.3–1.5 0–0.44
Cough >3 weeks3,12 75%–97% 51%–59% 1.8–2.0 0.06–0.42
Whoop3,10–12 37%–90% 49%–96% 1.6–9.2 0.18–0.66
Posttussive 28%–84% 45%–84% 0.9–2.2 0.36–1.0
vomiting3,10,11,13
Paroxysms3,12,13 68%–94% 15%–45% 1.1–1.4 0.29–0.71
Household 20%–50% 73%–91% 1.9–2.2 0.68–0.88
exposure11,13
Afebrile 62%–96% 12%–54% 0.8–1.1 0–1.7
(temp <38ºC)11–13
Lymphocytosis3 88% 57% 2.0 0.21
LR+ = positive likelihood ratio: sensitivity/(1–specificity); † LR– = negative likelihood ratio: (1–sensitivity)/specificity.
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impact the epidemiology of pertussis in the US.
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Does quinine reduce 
leg cramps 
for young athletes?
■ EVIDENCE-BASED ANSWER
Very little evidence exists regarding the use of
quinine for cramps in young adult athletes.
Quinine may be an effective treatment for heat
cramps in athletes (strength of recommendation
[SOR]: C, 1 case series involving 2 patients).
Quinine is better established as an effective treat-
ment for nocturnal leg cramps in the general adult
population (SOR: A, 1 meta-analysis and 2 ran-
domized controlled trials).
■ EVIDENCE SUMMARY
Leg cramps (heat cramps) in athletes are
defined as painful involuntary muscle contrac-
tions, usually in the large muscle groups of the
legs, which occur during or in the hours follow-
ing exercise. Oral quinine is sometimes used to
treat nocturnal leg cramps in the general adult
and elderly populations. However, its use is 
controversial secondary to concerns regarding
efficacy and safety.
Efficacy of quinine in young athletes has not
been well studied. A case series reported on 
2 athletes: 1 college basketball player and 
1 professional football player.1 The basketball
player experienced heat cramps during games
that were resistant to hydration and dietary treat-
ment. A regimen of 60 mg oral quinine sulfate
taken 1 hour before game time and again at half-
time eliminated cramps during the first game and
the subsequent 15 games. The football player’s
heat cramps were only partially improved with
oral electrolyte repletion and oral hydration.
However, he suffered no further cramps after ini-
tiating a regimen of 120 mg oral quinine sulfate
12. Heininger U, Cherry JD, Eckhardt T, Lorenz C,
Christenson P, Stehr K. Clinical and laboratory diagnosis
of pertussis in the regions of a large vaccine efficacy trial
in Germany. Pediatr Infect Dis J 1993; 12:504–509.
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■ CLINICAL COMMENTARY
Infants may have complications; evaluate
if there is apnea or significant cough
Immunity to pertussis wanes following vaccina-
tion, leaving many adolescents and adults sus-
ceptible to infection. In older children and adults,
there is often little in the clinical presentation
that distinguishes chronic cough due to pertussis
from that associated with other causes.
Clinicians should consider evaluating for pertus-
sis in older children and adults with chronic
cough (>2 weeks) if there is reason to suspect
they have been exposed, if the cough is associat-
ed with inspiratory whoop, or if the individual has
household or frequent contact with infants. 
Infants may suffer severe complications from
pertussis, and should receive evaluation when
presenting with apnea or significant cough of any
duration. In current practice, evaluation usually
includes obtaining a nasopharyngeal swab for
culture and PCR, though these tests may be
insensitive, especially in later phases of illness.
The usefulness of single, quantitative
immunoglobulin G titers with comparison to pop-
